Cargando…

Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphisms

BACKGROUND: The use of methotrexate is limited by interindividual variability in response. Previous studies in patients with either rheumatoid arthritis or psoriasis suggest that genetic variation across the methotrexate metabolic pathway might enable prediction of both efficacy and toxicity of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Warren, RB, Smith, RL, Campalani, E, Eyre, S, Smith, CH, Barker, JNWN, Worthington, J, Griffiths, CEM
Formato:	Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2009
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2680291/ https://www.ncbi.nlm.nih.gov/pubmed/19016697 http://dx.doi.org/10.1111/j.1365-2133.2008.08898.x

Ejemplares similares

Polymorphisms in the PTPN22 region are associated with psoriasis of early onset
por: Smith, RhLl, et al.
Publicado: (2008)

A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real‐world populations in psoriasis
por: Yiu, Z.Z.N., et al.
Publicado: (2019)

Genetic susceptibility to psoriasis: an emerging picture
por: Smith, Rhodri Ll, et al.
Publicado: (2009)

Psoriasis treat to target: defining outcomes in psoriasis using data from a real‐world, population‐based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR)
por: Mahil, S.K., et al.
Publicado: (2019)

Comparative effectiveness of biological therapies on improvements in quality of life in patients with psoriasis
por: Iskandar, I.Y.K., et al.
Publicado: (2017)

Methotrexate (MTX) inhibition of cytokine production: relationship with clinical outcome and genetic polymorphisms
por: Sabina, P, et al.
Publicado: (2003)

Psoriasis and Genetics
por: DAND, Nick, et al.
Publicado: (2020)

Polymorphisms in methotrexate transporters and their relationship to plasma methotrexate levels, toxicity of high-dose methotrexate, and outcome of pediatric acute lymphoblastic leukemia
por: Liu, Shu-Guang, et al.
Publicado: (2017)

A liver fibrosis cocktail? Psoriasis, methotrexate and genetic hemochromatosis
por: Mathew, Joseph, et al.
Publicado: (2005)

Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta‐analysis of randomized controlled trials
por: Rungapiromnan, W., et al.
Publicado: (2017)

Persistence and effectiveness of nonbiologic systemic therapies for moderate‐to‐severe psoriasis in adults: a systematic review
por: Mason, K.J., et al.
Publicado: (2019)

Polymorphism in Gene for ABCC2 Transporter Predicts Methotrexate Drug Survival in Patients with Psoriasis
por: Grželj, Jasna, et al.
Publicado: (2021)

MTHFR Gene Polymorphism Association With Psoriatic Arthritis Risk and the Efficacy and Hepatotoxicity of Methotrexate in Psoriasis
por: Zhu, Jie, et al.
Publicado: (2022)

Apremilast or Methotrexate: The Arrows in the Quiver for Psoriasis
por: Panda, Gautam, et al.
Publicado: (2023)

Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
por: Yiu, Z.Z.N., et al.
Publicado: (2018)

Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study
por: Warren, R.B., et al.
Publicado: (2018)

MTHFR and MTRR Genetic Polymorphism of Methotrexate Therapy Outcomes in Early Rheumatoid Arthritis
por: Zhang, Qian, et al.
Publicado: (2023)

Risk of COVID‐19 infection in adult patients with atopic eczema and psoriasis: a single‐centre cross‐sectional study
por: Yiu, Z.Z.N., et al.
Publicado: (2021)

Efficacy of Methotrexate in patients with plaque type psoriasis
por: Haider, Sabiqa, et al.
Publicado: (2014)

Update on subcutaneous methotrexate for inflammatory arthritis and psoriasis
por: Vena, Gino Antonio, et al.
Publicado: (2018)

Nail psoriasis treated with intralesional methotrexate infiltration
por: Duarte, Artur Antônio, et al.
Publicado: (2019)

Polymorphisms within methotrexate pathway genes: Relationship between plasma methotrexate levels, toxicity experienced and outcome in pediatric acute lymphoblastic leukemia
por: Esmaili, Mohammad Ali, et al.
Publicado: (2020)

Association of the characteristics of the blood metabolome and gut microbiome with the outcome of methotrexate therapy in psoriasis
por: Qiu, Qinwei, et al.
Publicado: (2022)

Genetic polymorphisms associated with psoriasis and development of psoriatic arthritis in patients with psoriasis
por: Loft, Nikolai Dyrberg, et al.
Publicado: (2018)

Nitric Oxide Levels in Patients with Psoriasis Treated with Methotrexate
por: Tekin, Nilgun Solak, et al.
Publicado: (2006)

The possibilities and principles of methotrexate treatment of psoriasis – the updated knowledge
por: Czarnecka-Operacz, Magdalena, et al.
Publicado: (2014)

Ulcerations due to methotrexate toxicity in a psoriasis patient
por: Souza, Claudia Fernanda Dias, et al.
Publicado: (2016)

Effects of methotrexate and etanercept treatment in moderate and severe psoriasis
por: Benites, Elizabeth, et al.
Publicado: (2022)

Risk of major cardiovascular events in patients with psoriasis receiving biologic therapies: a prospective cohort study
por: Rungapiromnan, W., et al.
Publicado: (2019)

Switching from a fumaric acid ester mixture to dimethylfumarate monotherapy in psoriasis
por: Warren, R.B., et al.
Publicado: (2019)

Nonadherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis
por: Thorneloe, R.J., et al.
Publicado: (2016)

Genetics of RA susceptibility, what comes next?
por: Ding, James, et al.
Publicado: (2015)

A Comparative Study of the Efficacy of Methotrexate versus Methotrexate with Apremilast in Moderate to Severe Chronic Plaque Psoriasis
por: Srivastava, Divyanshu, et al.
Publicado: (2023)

Development and validation of a multivariable risk prediction model for serious infection in patients with psoriasis receiving systemic therapy
por: Yiu, Z.Z.N., et al.
Publicado: (2019)

Acute methotrexate toxicity presenting as ulcers in plaques of psoriasis vulgaris
por: Bhatnagar, Anuj, et al.
Publicado: (2015)

Méthotrexate et psoriasis: à propos de 46 cas
por: Inani, Kawtar, et al.
Publicado: (2014)

A Case of Nail Psoriasis Successfully Treated with Intralesional Methotrexate
por: Mokni, Sana, et al.
Publicado: (2018)

Bullous pemphigoid associated with psoriasis: a good response to methotrexate
por: Vargas, Pablo, et al.
Publicado: (2019)

The Combined Use of Metformin and Methotrexate in Psoriasis Patients with Metabolic Syndrome
por: Tam, Huynh Thi Xuan, et al.
Publicado: (2022)

Shikonin combined with methotrexate regulate macrophage polarization to treat psoriasis
por: Tao, Tingjun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ihno4qvl6r9d6jvg38ght38p7a